Status:
COMPLETED
Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to perform pooled analysis with data collected from 5 previously published studies and 8 unpublished datasets collected from international sites. The main goal of this stu...
Detailed Description
Plaque erosion is reported to be responsible for about one third of patients with acute coronary syndrome (ACS). In the EROSION study, we reported that antithrombotic therapy without stenting achieved...
Eligibility Criteria
Inclusion
- Diagnosed with ACS upon admission to hospital, including patients with ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina pectoris (UAP).
- Intra-vascular OCT imaging of culprit vessel.
Exclusion
- None
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
1793 Patients enrolled
Trial Details
Trial ID
NCT03479723
Start Date
December 1 2017
End Date
August 1 2024
Last Update
December 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114